COMUNICADO: SPRYCEL(R) (dasatinib) Receives CHMP Positive Opinion for the Treatment of Adult Patients With Newly Diagnosed Philadelp

Actualizado 22/10/2010 17:36:52 CET


References
1. Kantarjian H, et al. N Engl J Med. 2010 Jun 17;362(24):2260-70.
2. Branford S. Hematology. 2007:376-83.
3. Hughes T, et al. Blood. 2006;108:28-37
4. Baccarani, M. and Dreyling, M. Annals of Oncology. 2010;21:165-167

---------------------------------

[*] Complete cytogenetic response (CCyR) is defined as the absence of Philadelphia chromosome-positive metaphases on cytogenetic assessment of bone marrow cells.

[**] Major molecular response (MMR) is defined as a BCR-ABL transcript level of [less than or equal to]0.1% (3 log reduction) as measured by real-time quantitative polymerase chain reaction (RQ-PCR) of peripheral blood.

[TAB]

Contacts:

Bristol-Myers Squibb,

European Media Contact:

Elzbieta Zawislak, +33615523580, elzbieta.zawislak@bms.com .

[FTAB]

CONTACT: Contacts: Bristol-Myers Squibb, European Media Contact: ElzbietaZawislak, +33615523580, elzbieta.zawislak@bms.com .

Mejora la comunicación de tu empresa con Europa Press Comunicación

Mejora la comunicación de tu empresa con Europa Press Comunicación